These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6390722)

  • 1. A preoperative chymopapain sensitivity test for chemonucleolysis candidates.
    Tsay YG; Jones R; Calenoff E; Sun J; Arndt L; Crispin B; Rock H
    Spine (Phila Pa 1976); 1984 Oct; 9(7):764-8. PubMed ID: 6390722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chymopapain-induced hypersensitivity following chemonucleolysis.
    Tsay YG; Jones R; Calenoff E; Sun J; Arndt L; Crispin B; McDermott D; Stern I
    Spine (Phila Pa 1976); 1984 Oct; 9(7):769-71. PubMed ID: 6390723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactivity of IgE and IgG serum levels to chymopapain after chemonucleolysis.
    Sagona MA; Bruszer GV; Nelson JC; Mascoli C; Serkes K
    J Allergy Clin Immunol; 1985 Jun; 75(6):659-62. PubMed ID: 3891823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between hypersensitivity to parenteral chymopapain and the presence of IgE anti-chymopapain antibody.
    Kapsalis AA; Stern IJ; Bornstein I
    Clin Exp Immunol; 1978 Jul; 33(1):150-8. PubMed ID: 709910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin testing for chymopapain allergy in chemonucleolysis.
    Mayer HM; Wehr M; Brock M; Kaden B
    Surg Neurol; 1986 Mar; 25(3):283-9. PubMed ID: 3945910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretreatment serum levels of IgE to chymopapain in reactive patients.
    Sagona MA; Bruszer G; Pearson F; Mascoli CC; Serkes K
    Ann Allergy; 1985 Nov; 55(5):674-7. PubMed ID: 4061973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of chymopapain anaphylaxis by screening chemonucleolysis candidates with cutaneous chymopapain testing.
    Grammer LC; Schafer M; Bernstein D; Bernstein IL; Cogen F; Dolovich J; Schatz M; Zeiger R; Shaughnessy JJ; Gutt L
    Clin Orthop Relat Res; 1988 Sep; (234):12-5. PubMed ID: 3409565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chymopapain allergy. Diagnostic value of a skin test before and after chemonucleolysis].
    Mayer HM; Brock M
    Neurochirurgia (Stuttg); 1985 Mar; 28(2):51-6. PubMed ID: 3887196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chymopapain chemonucleolysis in lumbar disk disease.
    Russell AS
    JAMA; 1975 Sep; 233(11):1164. PubMed ID: 1174165
    [No Abstract]   [Full Text] [Related]  

  • 10. [Sensitization to chymopapain in patients treated with chemonucleolysis].
    García-Ortega P; Ramírez Ferreiras W; Sancho A; Urías S; Cisteró A
    Med Clin (Barc); 1991 Mar; 96(11):410-2. PubMed ID: 2046428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Skin tests and chymopapain-specific immunoglobulins E after chemonucleolysis].
    Cornaille G; Guérin B; Leynadier F; Menkes CJ; Dry J
    Presse Med; 1987 May; 16(18):881-4. PubMed ID: 2954117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of intervertebral disc disease treatment by chymopapain injection and open surgery.
    Watts C; Hutchison G; Stern J; Clark K
    J Neurosurg; 1975 Apr; 42(4):397-400. PubMed ID: 1123657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective evaluation of chymopapain sensitivity in patients undergoing chemonucleolysis.
    Bernstein DI; Gallagher JS; Ulmer A; Bernstein IL
    J Allergy Clin Immunol; 1985 Sep; 76(3):458-65. PubMed ID: 3897344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemonucleolysis.
    Connolly RC
    J Bone Joint Surg Br; 1977 Feb; 59(1):1. PubMed ID: 845224
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of chymopapain chemonucleolysis. A long-term review of 105 patients.
    Javid MJ
    J Neurosurg; 1985 May; 62(5):662-6. PubMed ID: 3886850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chymopapain chemonucleolysis. A preliminary report.
    Ravichandran G; Mulholland RC
    Spine (Phila Pa 1976); 1980; 5(4):380-4. PubMed ID: 7006098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chymopapain.
    Einarson TR; Bootman JL; Smith GH
    Drug Intell Clin Pharm; 1984; 18(7-8):560-8. PubMed ID: 6378565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoglobulin E antibodies to papaya proteinases and their relevance to chemonucleolysis.
    Dando PM; Sharp SL; Buttle DJ; Barrett AJ
    Spine (Phila Pa 1976); 1995 May; 20(9):981-5. PubMed ID: 7631245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chymopapain in the treatment of ruptured lumbar discs. Preliminary experience in 48 patients.
    Maroon JC; Holst RA; Osgood CP
    J Neurol Neurosurg Psychiatry; 1976 May; 39(5):508-13. PubMed ID: 778345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Letter: Chymopapain chemonucleolysis in lumbar disk disease.
    JAMA; 1975 Oct; 234(3):271-4. PubMed ID: 1174238
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.